KCT0004323
Completed
未知
A single-center prospective, cohort study on the safety and efficacy of laparoscopic surgical robot, Revo-i(MSR-5100)
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Yonsei University Health System, Severance Hospital
- Enrollment
- 10
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
Robotic surgeries have become readily, and widely available worldwide. There is a limited choice for system provider Revo-i has proved to be just as safe and feasible as other minimally invasive surgery we perform, according to our data. We hope that competition among robotic system market may provide us with improved systems at better prices. Revo-I system is compatible to other MIS systems commonly used at the moment It provides all the advantages of robotic system and at a lower cost, which has been the main drawback of robotic surgeries
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Adults over 19
- •2\) Voluntary consent to clinical research and be willing to comply with the protocol
- •3\) A person who needs to have a resection for colon and rectal cancer
- •\-Histopathologically confirmed by adenocarcinoma of the rectum or colon
- •\-No remote metastasis (M0\)
- •\-Primary tumor without other peripheral organ involvement (T1\-T4a)
- •\-When intestinal obstruction is not accompanied
- •\-In case of elective surgery
- •\-Does not require resection of any organ other than the primary tumor
- •4\) Others who have been diagnosed as having to receive a colon and rectal resection according to the researcher's judgment
Exclusion Criteria
- •1\) Have mental illness or serious systemic disease
- •2\) Body Mass Index (BMI) \= 30, high obesity
- •3\) General anesthesia is not possible due to uncontrolled bleeding tendency or lowering of cardiopulmonary function
- •4\) Have a positive pregnancy or be preparing for pregnancy
- •5\) Wish to undergo conventional laparoscopy or da Vinci robotic surgery
- •6\) Have a history of lower abdominal and pelvic laparotomy
- •7\) Prone to bleeding
- •8\) Older than 80 years old
- •9\) In case of remote metastasis (M1\)
- •10\) Adjacent organ invasion (T4b) or require a resection of any organ other than the primary tumor
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
To Evaluate the Effectiveness and Safety of the Single-port Robotic-assisted Breast Surgery in Breast CancerBreast CancerNCT06561646The First Affiliated Hospital with Nanjing Medical University60
Not yet recruiting
Not Applicable
To Evaluate the Effectiveness and Safety of Single-port Robotic-assisted Subcutaneous Gland Resection Combined With Immediate Breast Reconstruction in Breast CancerBreast CancerNCT06706726The First Affiliated Hospital with Nanjing Medical University40
Recruiting
Not Applicable
Robot-assisted vs. Open Nipple-sparing Mastectomy With Immediate Breast ReconstructionNCT05490433Yonsei University790
Completed
Not Applicable
A Novel Robotic System for Single Port and Natural Orifice Transluminal Endoscopic SurgeryColorectal NeoplasmsUrologic NeoplasmsUrologic DiseasesNasopharyngeal NeoplasmsOropharyngeal NeoplasmsOral NeoplasmsHypopharyngeal NeoplasmsLaryngeal NeoplasmsENT DiseasesNCT03010813Chinese University of Hong Kong63
Completed
Not Applicable
Robotic Assisted Surgery for Treatment of Gynecological Diseases: Pilot StudyAdnexal DiseasesUterine DiseasesNCT03093675SOFAR S.p.A.150